ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Defibrillator Lead Performed Worse Than Competitor Lead -Study

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicenter study presented at a medical meeting Thursday. St. Jude stopped selling the Riata leads in 2010, but about 79,000 are still implanted in patients in the U.S. St. Jude said last year it was recalling them due to a tendency for the metal wires to wear through their silicone covering. Data in the study, presented at the Heart Rhythm Society meeting in Boston, was collected retrospectively from seven centers. Researchers evaluated the leads for all causes of failure, including cases where cables wore through their coating and electrical malfunctions. Riata, but not Riata ST, leads performed significantly worse than Quattro, according to the study. But follow-up for Riata ST was shorter than it was for Riata. The study also found that nearly a third of leads with exposed cables were malfunctioning. St. Jude said in a statement that the data is consistent with the company's findings that significant design changes implemented in the Riata ST leads resulted in improved performance compared to the Riata leads. In March, a study authored by Robert G. Hauser, a Minnesota cardiologist, tied a malfunction in Riata to at least 20 deaths. Dr. Hauser said the deaths alleged from Riata malfunctions were about nine times greater than Quattro. Last month, St. Jude said it was seeking a retraction of the study, published in the Heart Rhythm Journal. The company says Dr. Hauser undercounted deaths linked to Quattro. St. Jude shares were up 2.3% to $40.12 in recent trading. The stock is down 24% in the last year. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
03/24/201709:00:43New Guidelines Support Use of Cardiac Monitoring for Patients...
03/23/201709:15:52Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201709:15:52Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201706:04:44Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201706:04:44Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/22/201717:47:00Medtronic Files 8K - Other Events
03/22/201717:18:26Current Report Filing (8-k)
03/22/201715:50:01Amended Statement of Changes in Beneficial Ownership (4/a)
03/22/201709:00:48Medtronic Receives FDA Approval for CoreValve(TM) Evolut(TM...
03/22/201708:30:00Big Data Poses Big Headaches as Health Care Industry Adopts HIT...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:04:18Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/21/201720:00:22Medtronic Announces Pricing of $2 Billion of Senior Notes
03/21/201718:08:55Statement of Changes in Beneficial Ownership (4)
03/21/201708:44:37Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:44:37Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:42:28Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:42:28Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US